247 related articles for article (PubMed ID: 17545743)
1. Memantine for behavioral disturbances in frontotemporal dementia: a case series.
Swanberg MM
Alzheimer Dis Assoc Disord; 2007; 21(2):164-6. PubMed ID: 17545743
[TBL] [Abstract][Full Text] [Related]
2. A 6-month, open-label study of memantine in patients with frontotemporal dementia.
Diehl-Schmid J; Förstl H; Perneczky R; Pohl C; Kurz A
Int J Geriatr Psychiatry; 2008 Jul; 23(7):754-9. PubMed ID: 18213609
[TBL] [Abstract][Full Text] [Related]
3. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
[TBL] [Abstract][Full Text] [Related]
5. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
Gauthier S; Loft H; Cummings J
Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia.
Srikanth S; Nagaraja AV; Ratnavalli E
J Neurol Sci; 2005 Sep; 236(1-2):43-8. PubMed ID: 15964021
[TBL] [Abstract][Full Text] [Related]
7. [Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria].
Schmidt R; Baumhackl U; Berek K; Brücke T; Kapeller P; Lechner A; Rainer M; Stögerer EM
Neuropsychiatr; 2010; 24(2):125-31. PubMed ID: 20605008
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic dose-sparing effect with addition of memantine.
Sleeper RB
Ann Pharmacother; 2005 Sep; 39(9):1573-6. PubMed ID: 16076907
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment of dementia.
Schwarz S; Froelich L; Burns A
Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
[TBL] [Abstract][Full Text] [Related]
11. [Frontotemporal dementia].
Nagy R; Heuckmann J; Mennel HD; Klosterkötter J; Kuhn J
Med Klin (Munich); 2007 Oct; 102(10):816-23. PubMed ID: 17928965
[TBL] [Abstract][Full Text] [Related]
12. A case of apathy due to frontotemporal dementia responsive to memantine.
Links KA; Black SE; Graff-Guerrero A; Wilson AA; Houle S; Pollock BG; Chow TW
Neurocase; 2013; 19(3):256-61. PubMed ID: 22515731
[TBL] [Abstract][Full Text] [Related]
13. [Memantine for the treatment of dementia].
van Gool WA; Eikelenboom P
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2101-2. PubMed ID: 14619198
[TBL] [Abstract][Full Text] [Related]
14. Aggressive and impulsive behaviors in Frontotemporal dementia and Alzheimer's disease.
Grochmal-Bach B; Bidzan L; Pachalska M; Bidzan M; Łukaszewska B; Pufal A
Med Sci Monit; 2009 May; 15(5):CR248-54. PubMed ID: 19396041
[TBL] [Abstract][Full Text] [Related]
15. Memantine in behavioral variant frontotemporal dementia: negative results.
Vercelletto M; Boutoleau-Bretonnière C; Volteau C; Puel M; Auriacombe S; Sarazin M; Michel BF; Couratier P; Thomas-Antérion C; Verpillat P; Gabelle A; Golfier V; Cerato E; Lacomblez L;
J Alzheimers Dis; 2011; 23(4):749-59. PubMed ID: 21157021
[TBL] [Abstract][Full Text] [Related]
16. Frontotemporal dementia mimicking dementia with Lewy bodies.
Claassen DO; Parisi JE; Giannini C; Boeve BF; Dickson DW; Josephs KA
Cogn Behav Neurol; 2008 Sep; 21(3):157-63. PubMed ID: 18797258
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of neuropsychiatric symptoms in elderly patients with dementia in Mungialde County (Basque Country, Spain).
Fernández Martínez M; Castro Flores J; Pérez de las Heras S; Mandaluniz Lekumberri A; Gordejuela Menocal M; Zarranz Imirizaldu JJ
Dement Geriatr Cogn Disord; 2008; 25(2):103-8. PubMed ID: 18063866
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
Cummings JL; Mackell J; Kaufer D
Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
[TBL] [Abstract][Full Text] [Related]
19. Clock drawing and frontal lobe behavioral effects of memantine in Alzheimer's disease: a rater-blinded study.
Paskavitz JF; Gunstad JJ; Samuel JE
Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):454-9. PubMed ID: 17267379
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
J Neurol Sci; 2014 Jan; 336(1-2):103-8. PubMed ID: 24189208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
